Stock screener
Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
290 stocks
Prices and filings as of the close on Oct 30, 2026
| # | Company | Share price | 1D | Market cap | Gross margin | Op. margin | Net margin | FCF margin | ROE | ROIC | ROE 5Y |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | $504.80 | −10.9% | $824B | 53.2% | 15.7% | 15.6% | 20.3% | 10.1% | 9.7% | 12.7% | |
| 2 | $406.97 | −0.96% | $365B | 88.6% | 4.8% | 3.1% | 5.2% | – | – | – | |
| 3 | $250.43 | −4.1% | $256B | 75.2% | −2.2% | 1.1% | 29.8% | 1.3% | −65.8% | −8.1% | |
| 4 | $306.08 | −7.3% | $108B | 67.0% | −22.8% | −20.1% | 22.0% | −46.0% | – | −26.0% | |
| 5 | $840.70 | −8.6% | $75.4B | 41.7% | 17.4% | −230% | 10.0% | −240% | 10.4% | −56.5% | |
| 6 | $52.15 | +1.9% | $57.4B | – | – | 16.7% | 23.9% | 11.5% | – | 35.4% | |
| 7 | $258.70 | −10.9% | $44.9B | 75.1% | 22.8% | 30.7% | 23.0% | 25.8% | 101% | – | |
| 8 | $274.37 | −7.4% | $42.9B | 59.3% | 32.1% | 27.5% | 20.5% | 42.9% | 47.3% | 25.8% | |
| 9 | $32.12 | +0.38% | $42.2B | 26.4% | 7.8% | 4.1% | 4.6% | 10.0% | 9.6% | – | |
| 10 | $191.31 | +0.55% | $41.0B | – | – | – | – | −79.1% | – | −39.1% | |
| 11 | $83.63 | −0.82% | $34.3B | 38.5% | 19.6% | 11.9% | – | 17.3% | 13.5% | – | |
| 12 | $54.73 | −7.4% | $32.7B | 37.3% | −29.1% | −21.5% | −48.3% | −7.9% | −28.1% | −30.6% | |
| 13 | $54.87 | −9.7% | $30.3B | 67.4% | −3.0% | −25.4% | −180% | −50.2% | −3.0% | – | |
| 14 | $36.91 | −1.6% | $26.7B | – | −7915% | −3535% | −10901% | −6.2% | −407% | −1.7% | |
| 15 | $124.15 | −7.1% | $25.7B | 80.2% | −18.3% | −16.5% | 19.7% | – | – | – | |
| 16 | $73.47 | −1.8% | $24.8B | – | 9.8% | 45.3% | 23.3% | 45.1% | 15.0% | −7.6% | |
| 17 | $91.73 | −29.2% | $17.6B | 91.4% | 28.2% | 31.3% | 36.7% | 30.7% | 188% | – | |
| 18 | $343.12 | −1.6% | $16.4B | – | 2.6% | – | 16.5% | – | 0.92% | – | |
| 19 | $94.39 | −4.5% | $11.6B | 77.9% | −11.5% | −7.3% | 28.3% | −4.9% | −31.1% | −10.5% | |
| 20 | $21.65 | −3.0% | $11.5B | 79.1% | −124% | −123% | 18.1% | −109% | – | – | |
| 21 | $11.04 | −3.0% | $11.5B | 24.0% | −3.4% | −5.2% | 1.4% | −5.0% | −2.2% | −4.0% | |
| 22 | $57.50 | +1.2% | $11.2B | 96.0% | 7.0% | 2.3% | −20.3% | 1.8% | 4.6% | 10.2% | |
| 23 | $83.53 | −0.64% | $10.8B | – | 4.7% | −19.4% | – | −16.7% | 2.7% | −26.2% | |
| 24 | $77.02 | −1.2% | $10.6B | – | 2.4% | −0.64% | – | −0.64% | 0.56% | −0.79% | |
| 25 | $24.30 | −7.2% | $9.9B | 69.9% | −94.7% | −91.8% | −8.7% | – | – | – | |
| 26 | $332.29 | +2.4% | $9.8B | – | 44.9% | 54.8% | 58.5% | 20.1% | 45.3% | −2.0% | |
| 27 | $110.19 | −1.1% | $9.6B | – | 53.6% | 38.6% | – | 15.6% | 17.7% | 10.9% | |
| 28 | $56.15 | −4.8% | $9.4B | 68.9% | 21.9% | 16.1% | 24.6% | 11.1% | 12.9% | 11.6% | |
| 29 | $30.37 | −1.4% | $9.4B | – | 4.1% | 3.6% | 28.6% | 34.3% | – | −276% | |
| 30 | $61.18 | +5.3% | $9.4B | 82.4% | 17.1% | 55.2% | 2.2% | 100% | 27.8% | −23.4% | |
| 31 | $35.92 | +0.17% | $8.6B | – | – | 38.3% | 22.7% | 11.2% | – | – | |
| 32 | syreSpyre Therapeutics | $96.56 | −2.4% | $8.5B | – | – | – | – | −23.0% | – | −111% |
| 33 | $53.76 | −0.83% | $8.3B | – | – | 13.5% | 12.8% | 33.6% | – | 23.3% | |
| 34 | $28.52 | 0.00% | $8.3B | – | – | – | – | – | – | – | |
| 35 | $76.29 | −1.9% | $8.3B | – | – | 486% | – | 13.1% | – | 16.1% | |
| 36 | $41.00 | −1.3% | $7.9B | – | 62.3% | 40.4% | – | 8.7% | 10.6% | 8.6% | |
| 37 | $25.81 | −9.0% | $7.9B | 35.0% | 12.9% | 5.8% | −0.48% | 14.5% | 14.5% | – | |
| 38 | $23.38 | −1.7% | $7.7B | 15.0% | 9.5% | 5.1% | 3.5% | 12.3% | 9.3% | 1.7% | |
| 39 | $110.90 | −3.4% | $7.7B | 30.8% | 10.5% | 5.4% | 8.1% | 8.2% | 7.6% | 14.7% | |
| 40 | $47.81 | −3.8% | $7.6B | 23.5% | 7.4% | 4.8% | – | 28.1% | 29.4% | – | |
| 41 | $65.55 | +1.0% | $7.4B | 29.0% | −16.1% | −0.28% | 20.8% | – | – | – | |
| 42 | $59.40 | −10.6% | $7.3B | 62.3% | −295% | −189% | – | −44.3% | −65.7% | – | |
| 43 | $18.34 | −1.1% | $7.2B | 13.4% | 8.6% | 6.8% | 5.2% | 15.9% | 13.9% | 12.0% | |
| 44 | $24.34 | +0.12% | $6.9B | – | – | −16.8% | – | −6.3% | – | −5.4% | |
| 45 | $165.13 | −3.8% | $6.8B | 81.1% | 6.1% | 5.6% | 21.3% | 32.8% | – | 26.9% | |
| 46 | $26.10 | −2.0% | $6.8B | 72.5% | −25.7% | −42.1% | 5.5% | −540% | – | – | |
| 47 | $322.75 | +1.7% | $6.4B | – | 10.1% | 20.3% | 35.7% | 5.4% | 2.6% | 4.7% | |
| 48 | $96.87 | +0.23% | $6.4B | – | – | – | – | −18.2% | −95.6% | −24.8% | |
| 49 | $51.31 | +3.3% | $6.3B | 44.3% | – | 18.6% | 19.2% | 711% | – | 584% | |
| 50 | $16.00 | −11.7% | $6.3B | – | – | −0.49% | −3.3% | −16.7% | – | – |